Roivant Sciences Ownership & Insider Activity

Roivant Sciences Ltd

ROIVNASDAQ

Trade with Public

$37.11

0.571.56%

마지막 업데이트: Oct 28, 6:29 PM

개요 뉴스 실적 전망 이벤트 목표가 재무 심리지분 현황비교 옵션 주식 보고서

실적: Q2 2027 실적이 월 11월 9th에 개장 전 12일 후 후에 발표됩니다.

Roivant Sciences Ownership & Insider Activity

Roivant Sciences (ROIV) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 13.4% of shares outstanding. Institutional investors hold 48.3%. Over the past 90 days, insiders made 3 sales worth $7.4M.

Shares Outstanding

722.323M

Shares Float

548.531M

Insider Shares Owned

96.849M

Insider % Owned

13.4%

Institutional Shares Held

348.583M

Institutional % Held

48.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$7.4M total

Net Activity

Net Selling

Net Value (90d)

-$7.4M

Roivant Sciences Insider Transactions (Last 6 Months)

모든 내부자 거래 내역 보기 →

Date	Insider	Title	Type	Shares	Price	Value
Oct 20, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL	200.000K	$35.11	$7.0M
Oct 1, 2026	Melissa Epperly	DIRECTOR	SELL-OPTIONS	—	$20.28	$562K
Sep 30, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$20.23	$6.6M
Sep 15, 2026	Melissa Epperly	DIRECTOR	SELL	4.938K	$39.74	$196K
Sep 15, 2026	Meghan FitzGerald	DIRECTOR	SELL	5.112K	$39.74	$203K
Sep 8, 2026	Meghan FitzGerald	—	SELL-OPTIONS	—	$24.35	$622K
Aug 28, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$19.81	$6.4M
Aug 19, 2026	Mayukh Sukhatme	PRESIDENT & CIO	SELL-OPTIONS	—	$20.36	$11.1M
Aug 14, 2026	Mayukh Sukhatme	PRESIDENT & CIO	SELL-OPTIONS	—	$20.10	$21.6M
Jul 27, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$19.40	$6.2M
Jun 30, 2026	Meghan FitzGerald	DIRECTOR	SELL-OPTIONS	—	$21.85	$261K
Jun 29, 2026	Melissa B Epperly	DIRECTOR	SELL-OPTIONS	—	$19.42	$531K
Jun 26, 2026	Keith Manchester	—	SELL	1.638M	$34.46	$56.4M
Jun 26, 2026	Dan Gold	—	SELL	1.438M	$34.32	$49.4M
Jun 26, 2026	QVT Financial LP	—	SELL	1.438M	$34.32	$49.4M
Jun 25, 2026	Mayukh Sukhatme	PRESIDENT & CIO	SELL-OPTIONS	—	$18.98	$30.3M
Jun 24, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$18.50	$5.9M
May 20, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL	34.483K	$17.22	$6.4M

Congressional Trading Activity

모든 정부 거래 내역 보기 →

Date	Member	Party	Chamber	Action	Amount
Oct 31, 2025	Lisa McClain	R	House	Sale	$1,001 - $15,000
Oct 30, 2025	Lisa McClain	R	House	Sale	$1,001 - $15,000
Oct 30, 2025	Lisa McClain	R	House	Purchase	$1,001 - $15,000
Jun 17, 2025	Lisa McClain	R	House	Purchase	$1,001 - $15,000

Roivant Sciences Ownership & Insider Activity

Roivant Sciences (ROIV) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 13.4% of shares outstanding. Institutional investors hold 48.3%. Over the past 90 days, insiders made 3 sales worth $7.4M.

Shares Outstanding

722.323M

Shares Float

548.531M

Insider Shares Owned

96.849M

Insider % Owned

13.4%

Institutional Shares Held

348.583M

Institutional % Held

48.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$7.4M total

Net Activity

Net Selling

Net Value (90d)

-$7.4M

Roivant Sciences Insider Transactions (Last 6 Months)

모든 내부자 거래 내역 보기 →

Date	Insider	Title	Type	Shares	Price	Value
Oct 20, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL	200.000K	$35.11	$7.0M
Oct 1, 2026	Melissa Epperly	DIRECTOR	SELL-OPTIONS	—	$20.28	$562K
Sep 30, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$20.23	$6.6M
Sep 15, 2026	Melissa Epperly	DIRECTOR	SELL	4.938K	$39.74	$196K
Sep 15, 2026	Meghan FitzGerald	DIRECTOR	SELL	5.112K	$39.74	$203K
Sep 8, 2026	Meghan FitzGerald	—	SELL-OPTIONS	—	$24.35	$622K
Aug 28, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$19.81	$6.4M
Aug 19, 2026	Mayukh Sukhatme	PRESIDENT & CIO	SELL-OPTIONS	—	$20.36	$11.1M
Aug 14, 2026	Mayukh Sukhatme	PRESIDENT & CIO	SELL-OPTIONS	—	$20.10	$21.6M
Jul 27, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$19.40	$6.2M
Jun 30, 2026	Meghan FitzGerald	DIRECTOR	SELL-OPTIONS	—	$21.85	$261K
Jun 29, 2026	Melissa B Epperly	DIRECTOR	SELL-OPTIONS	—	$19.42	$531K
Jun 26, 2026	Keith Manchester	—	SELL	1.638M	$34.46	$56.4M
Jun 26, 2026	Dan Gold	—	SELL	1.438M	$34.32	$49.4M
Jun 26, 2026	QVT Financial LP	—	SELL	1.438M	$34.32	$49.4M
Jun 25, 2026	Mayukh Sukhatme	PRESIDENT & CIO	SELL-OPTIONS	—	$18.98	$30.3M
Jun 24, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL-OPTIONS	—	$18.50	$5.9M
May 20, 2026	Eric Venker	PRESIDENT & IMMUNOVANT CEO	SELL	34.483K	$17.22	$6.4M

Congressional Trading Activity

모든 정부 거래 내역 보기 →

Date	Member	Party	Chamber	Action	Amount
Oct 31, 2025	Lisa McClain	R	House	Sale	$1,001 - $15,000
Oct 30, 2025	Lisa McClain	R	House	Sale	$1,001 - $15,000
Oct 30, 2025	Lisa McClain	R	House	Purchase	$1,001 - $15,000
Jun 17, 2025	Lisa McClain	R	House	Purchase	$1,001 - $15,000

실적: Q2 2027 실적이 월 11월 9th에 개장 전 12일 후 후에 발표됩니다.

Roivant Sciences Ltd

Roivant Sciences Ownership & Insider Activity

Roivant Sciences Insider Transactions (Last 6 Months)

Congressional Trading Activity

뉴스

파트너 / 기고자

벤징가 글로벌

Roivant Sciences Ownership & Insider Activity

Roivant Sciences Insider Transactions (Last 6 Months)

Congressional Trading Activity

People Also Watch

People Also Watch